Physician

Abraham Chachoua, M.D.

According to 2025 Medicare claims, Abraham Chachoua, M.D. (NPI: 1518968643) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 10016-4744.

Chachoua's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 309 traditional Medicare patients, billed 675 HCPCS/CPT codes, and received $46,430 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 405 prescription claims across 91 beneficiaries totaling $611,466 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 46 claims. Open Payments data shows 1 records totaling $23. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $55,081 and ending at $46,430. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,696,439 to $611,466. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,527 and ending at $3,014.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	371	1,155	$55,081
2016	390	1,393	$108,584
2017	392	1,753	$176,383
2018	361	1,509	$157,122
2019	378	1,675	$182,092
2020	332	826	$53,313
2021	346	1,022	$59,720
2022	360	1,125	$65,340
2023	343	762	$57,450
2024	309	675	$46,430

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	156	843	$1,696,439
2016	119	476	$675,672
2017	109	336	$454,491
2018	97	327	$105,561
2019	102	275	$144,383
2020	86	323	$362,911
2021	98	278	$637,873
2022	129	441	$519,919
2023	106	411	$932,802
2024	91	405	$611,466

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	47	$2,657
2016	N/R	24	$1,859
2017	25	94	$4,216
2018	N/R	90	$3,999
2019	N/R	67	$1,822
2020	N/R	78	$3,062
2021	N/R	64	$2,707
2022	N/R	84	$4,201
2023	N/R	106	$5,544
2024	N/R	46	$2,629

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	24	24	$110
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	18	18	$85
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	213	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	223	381	$61
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	30	33	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	33	990	$540,638
Eliquis	Apixaban	24	710	$13,673
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	255	$266
Tizanidine Hcl	Tizanidine Hcl	12	360	$187
Zolpidem Tartrate	Zolpidem Tartrate	15	450	$167

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	28	$1,990
E1392	Portable oxygen concentrator, rental	Y	N/R	18	$639

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$23	Tempus AI, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abraham Chachoua, M.D.?

Tedicare shows public-source Medicare data for Abraham Chachoua, M.D. (NPI 1518968643), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Chachoua, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abraham Chachoua, M.D.?

Abraham Chachoua, M.D. is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Abraham Chachoua, M.D. have Open Payments data?

Abraham Chachoua, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.